Evidence map›Paper›PMID 40676136›Full record

ArticleScientific reports2025

Machine learning analysis of drug solubility via green approach to enhance drug solubility for poor soluble medications in continuous manufacturing.

Ahmed A Lahiq, Abdullah A Alshehri, Shaker T Alsharif

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ahmed A LahiqDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran, 66262, Saudi Arabia. aalahiq@nu.edu.sa.
Abdullah A AlshehriDepartment of Clinical Pharmacy, College of Pharmacy, Taif University, Al Huwaya, Taif, 21944, Saudi Arabia.
Shaker T AlsharifDepartment of Pharmaceutical Science, College of Pharmacy, Umm Al-Qura University, Makkah, 21955, Saudi Arabia.

Funding

Taif University TU-DSPP-2025-24
6 · The paper itself

Abstract

The development of continuous pharmaceutical manufacturing is crucial and can be analyzed via advanced computational models. Machine learning is a strong computational paradigm that can be integrated into a continuous process to enhance the drugs' solubility and efficacy. In this research, a simulation method for estimating pharmaceutical solubility was considered in green solvents to develop the idea of continuous pharmaceutical manufacturing. Artificial intelligence strategies were utilized to apply models for fitting several solubility datasets. Using machine learning techniques, the solubility of Clobetasol Propionate (CP) was modeled at temperature values between 308 K and 348 K, and pressures in the range of 12.2 MPa to 35.5 MPa. In this research, two models-a neural network-based model called MLP (Multilayer Perceptron) and a probabilistic model called GPR (Gaussian Process Regression)-along with an ensemble voting model based on these two, were considered for modeling. A GWO (Grey Wolf Optimization) method was also used to tune their hyperparameters. All three models have significant performances on estimation of CP solubility. But the voting model, which is a combination of the other two models, is better than the other two models in terms of accuracy. The ensemble voting model, integrating MLP and GPR with GWO optimization, offers superior accuracy for predicting CP solubility, advancing continuous pharmaceutical manufacturing.

Indexed as

Green Chemistry TechnologyMachine LearningComputer SimulationNeural Networks, ComputerPharmaceutical PreparationsSolubilityPharmaceutical PreparationsDrug solubilityGreen solventMachine learningModelingPharmaceuticals

Identifiers

PMID40676136
PMCPMC12271447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.